Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0ZU8L
|
|||
Drug Name |
PMID25991433-Compound-J5
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
DANA-FARBER CANCER INSTITUTE, INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C36H32N8O2
|
|||
Canonical SMILES |
CN(C)CC=CC(=O)NC1=CC=CC(=C1)C(=O)NC2=CC=C(C=C2)NC3=NC=CC(=N3)C4=C5C=CC=CN5N=C4C6=CC=CC=C6
|
|||
InChI |
1S/C36H32N8O2/c1-43(2)22-9-15-32(45)38-29-13-8-12-26(24-29)35(46)39-27-16-18-28(19-17-27)40-36-37-21-20-30(41-36)33-31-14-6-7-23-44(31)42-34(33)25-10-4-3-5-11-25/h3-21,23-24H,22H2,1-2H3,(H,38,45)(H,39,46)(H,37,40,41)/b15-9+
|
|||
InChIKey |
OCZDPFMSAKKNRH-OQLLNIDSSA-N
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:124926
|
References | Top | |||
---|---|---|---|---|
REF 1 | c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015;25(8):849-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.